Technical Analysis for YMAB - Y-mAbs Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 38.66 1.90% 0.72
YMAB closed up 1.9 percent on Wednesday, August 5, 2020, on 42 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Aug 6
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical YMAB trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Bollinger Band Squeeze Range Contraction 1.90%
NR7 Range Contraction 1.90%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Y-mAbs Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody therapeutic products for cancer treatment in the United States. It is developing naxitamab for the treatment of pediatric patients with relapsed or refractory, high-risk neuroblastoma, as well as other GD2 positive tumors; and omburtamab for the treatment of pediatric patients with central nervous system/leptomeningeal metastases, desmoplastic small round cell tumors, diffuse intrinsic pontine glioma, and other B7-H3 positive tumors. The company has a license and research collaboration agreement with Memorial Sloan-Kettering Cancer Center. Y-mAbs Therapeutics, Inc. was founded in 2015 and is headquartered in New York, New York.
Biopharmaceutical Cancer Cancer Treatment Brain Tumor Neuroblastoma Glioma Diffuse Intrinsic Pontine Glioma Refractory

Is YMAB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 50.49
52 Week Low 14.16
Average Volume 233,551
200-Day Moving Average 33.49
50-Day Moving Average 41.67
20-Day Moving Average 38.41
10-Day Moving Average 37.28
Average True Range 2.13
ADX 15.43
+DI 23.00
-DI 26.37
Chandelier Exit (Long, 3 ATRs ) 36.99
Chandelier Exit (Short, 3 ATRs ) 40.09
Upper Bollinger Band 41.52
Lower Bollinger Band 35.29
Percent B (%b) 0.54
BandWidth 16.24
MACD Line -1.25
MACD Signal Line -1.32
MACD Histogram 0.0711
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 39.92
Resistance 3 (R3) 39.81 39.27 39.71
Resistance 2 (R2) 39.27 38.95 39.33 39.64
Resistance 1 (R1) 38.97 38.75 39.12 39.08 39.57
Pivot Point 38.43 38.43 38.51 38.49 38.43
Support 1 (S1) 38.13 38.11 38.28 38.24 37.75
Support 2 (S2) 37.59 37.91 37.65 37.68
Support 3 (S3) 37.29 37.59 37.61
Support 4 (S4) 37.40